Elisabeth Bjork

Entity
Individual
Business address
C/O Rocket Pharmaceuticals, Inc., 350 Fifth Avenue, Suite 7530, 10116 New York, NY
Signature Ownership
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Elisabeth Bjork has filed 10 SEC EDGAR filings since 4/22/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Aug 27, 2025 Aug 27, 2025 001-36829
4 Open Document Open Filing FORM 4 Jul 18, 2025 Jun 18, 2025 001-36829
4 Open Document Open Filing FORM 4 Oct 29, 2024 Sep 26, 2024 001-36829
4 Open Document Open Filing FORM 4 Jun 20, 2024 Jun 13, 2024 001-36829
4 Open Document Open Filing Jun 26, 2023 Jun 22, 2023 001-36829
4 Open Document Open Filing FORM 4 Jun 15, 2022 Jun 13, 2022 001-36829
4 Open Document Open Filing FORM 4 Jun 16, 2021 Jun 14, 2021 001-36829
4 Open Document Open Filing FORM 4 Jun 18, 2020 Jun 16, 2020 001-36829
4 Open Document Open Filing FORM 4 Apr 22, 2020 Apr 20, 2020 001-36829
3 Open Document Open Filing FORM 3 Apr 22, 2020 Apr 20, 2020 001-36829